India to Kenya: Ledipasvir Export Trade Route

The India to Kenya Ledipasvir corridor is one of India's established pharmaceutical export routes, with 4 shipments documented worth a combined $197.5K USD. The route is dominated by MYLAN LABORATORIES LIMITED , which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's ledipasvir manufacturing sector.

Across 2 active suppliers, the average shipment value stands at $49.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 79% of all shipments, consistent with ledipasvir's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 11.5%, placing it at rank #9 among India's top ledipasvir export destinations globally.

On the import side, key buyers of Indian ledipasvir in Kenya include KEMSA, , QUESTA CARE LIMITED , TO THE CONSIGNEE-. KEMSA, is the single largest importer with 1 shipments valued at $152.6K USD.

India's ledipasvir exports to Kenya are driven primarily by a handful of large-scale manufacturers. MYLAN LABORATORIES LIMITED with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Kenya benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MYLAN LABORATORIES LIMITED , ZYPHAR'S PHARMACEUTICS PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $49.4K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as asper invoice no: zppl/xp/2324/222 date:02/12/2023 sr no. 65 ledipasvir 90 mg &sofosbuvir 400mg tablets 28's, suggesting that buyers in Kenya tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, KEMSA, is the largest importer with 1 shipments worth $152.6K USD — representing 77% of all ledipasvir imports from India on this route.